cb 10375 has been researched along with Ovarian Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, N; Coley, HM; Jarman, M; Judson, IR; Thornton, TJ | 1 |
| Brooks, N; Coley, HM; Goddard, PM; Halbert, GW; Jarman, M; Jones, M; Judson, IR; Kubota, T; Lee, N; Owens, MD | 1 |
| Balmanno, K; Calvert, AH; Gore, ME; Gumbrell, LA; Judson, IR; Perren, T; Wiltshaw, E | 1 |
| Abel, G; Ashley, SE; Cairnduff, F; Calvert, AH; Evans, BD; Graham, MA; Gumbrell, LA; Judson, IR; Rutty, CJ; Wilman, DE | 1 |
| Boven, E; Erkelens, CA; Nauta, MM; Pinedo, HM; Schlüper, HM | 1 |
2 trial(s) available for cb 10375 and Ovarian Neoplasms
| Article | Year |
|---|---|
Phase II trial of trimelamol in refractory ovarian cancer.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Middle Aged; Ovarian Neoplasms; Triazines | 1991 |
Phase I trial and pharmacokinetics of trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine).
Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasms; Ovarian Neoplasms; Triazines; Vomiting | 1989 |
3 other study(ies) available for cb 10375 and Ovarian Neoplasms
| Article | Year |
|---|---|
Stable analogues of the antitumour agent trimelamol retain in vitro cytotoxicity in drug-sensitive and resistant rodent and human cell lines.
Topics: Animals; Antineoplastic Agents; Cell Death; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Female; Humans; Mice; Ovarian Neoplasms; Platinum Compounds; Time Factors; Triazines; Tumor Cells, Cultured | 1994 |
Pre-clinical development of the anti-tumour agent CB 7646, bis N-(hydroxymethyl) trimethylmelamine, a stable analogue of trimelamol.
Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Cisplatin; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Drug Stability; Female; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nervous System Diseases; Ovarian Neoplasms; Plasmacytoma; Rats; Rats, Wistar; Solutions; Transplantation, Heterologous; Triazines; Tumor Cells, Cultured; Water | 1996 |
Superior efficacy of trimelamol to hexamethylmelamine in human ovarian cancer xenografts.
Topics: Altretamine; Animals; Antineoplastic Agents; Female; Humans; Kinetics; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Transplantation, Heterologous; Triazines | 1986 |